---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286315856.md"
description: "Precigen shares are trading higher after the company reported Q1 sales results."
datetime: "2026-05-13T20:45:53.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286315856.md)
  - [en](https://longbridge.com/en/news/286315856.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286315856.md)
---

# 

Precigen shares are trading higher after the company reported Q1 sales results.

### Related Stocks

- [PGEN.US](https://longbridge.com/en/quote/PGEN.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)

## Related News & Research

- [Precigen Q1 revenue beats estimates on PAPZIMEOS launch](https://longbridge.com/en/news/286311056.md)
- [Korro Bio To Advance KRRO-111 As Potential Treatment For AATD](https://longbridge.com/en/news/287089978.md)
- [BUZZ-Street View: Regeneron's melanoma trial setback raises bigger-picture questions](https://longbridge.com/en/news/286769076.md)
- [Co-Diagnostics Advances Ebola Preparedness With New Bundibugyo Virus Assay Strategy; Stock Up](https://longbridge.com/en/news/286956797.md)
- [Roivant posts unexpected Q4 profit due to Moderna lawsuit settlement gain](https://longbridge.com/en/news/287053604.md)